Last updated: 13 October 2022 at 11:09am EST

Georgina Wraight Net Worth




The estimated Net Worth of Georgina Wraight is at least $3.78 Million dollars as of 1 September 2022. Ms. Wraight owns over 20,046 units of Covetrus stock worth over $2,189,194 and over the last 5 years she sold CVET stock worth over $400,000. In addition, she makes $1,188,800 as Executive Vice President und President - Global Technology Solutions at Covetrus.

Ms. Wraight CVET stock SEC Form 4 insiders trading

Georgina has made over 12 trades of the Covetrus stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 20,046 units of CVET stock worth $420,766 on 1 September 2022.

The largest trade she's ever made was exercising 26,764 units of Covetrus stock on 14 January 2022 worth over $561,776. On average, Georgina trades about 7,923 units every 54 days since 2020. As of 1 September 2022 she still owns at least 104,297 units of Covetrus stock.

You can see the complete history of Ms. Wraight stock trades at the bottom of the page.





Georgina Wraight biography

Georgina Wraight serves as Executive Vice President, President - Global Technology Solutions of the Company. Prior to this, and from February 2019, Ms. Wraight served as Senior Vice President and President, Global Prescription Management. From August 2018 to February 2019, Ms. Wraight served as President, and from January 2018 to August 2018, as Chief Operating Officer of Vets First Choice. From November 2015 until August 2017, she served as Chief Operating Officer of the Rockport Company, a shoe manufacturer. From September 2012 to November 2015, Ms. Wraight served as Group Chief Financial Officer and then as Chief Operating Officer of Highline United & Modern Shoe Company. Ms. Wraight is a qualified Fellow Chartered Management Accountant (FCMA).

What is the salary of Georgina Wraight?

As the Executive Vice President und President - Global Technology Solutions of Covetrus, the total compensation of Georgina Wraight at Covetrus is $1,188,800. There are 2 executives at Covetrus getting paid more, with Benjamin Wolin having the highest compensation of $4,065,210.



How old is Georgina Wraight?

Georgina Wraight is 45, she's been the Executive Vice President und President - Global Technology Solutions of Covetrus since 2020. There are 23 older and 2 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.

What's Georgina Wraight's mailing address?

Georgina's mailing address filed with the SEC is 7, Custom House Street, India Street, Portland, Cumberland County, Maine, 04101, United States.

Insiders trading at Covetrus

Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin und Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.



What does Covetrus do?

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.



Complete history of Ms. Wraight stock trades at Covetrus

Insider
Trans.
Transaktion
Gesamtpreis
Georgina Wraight
See Remarks
Optionausübung $417,358
1 Sep 2022
Georgina Wraight
See Remarks
Optionausübung $33,957
1 Jun 2022
Georgina Wraight
See Remarks
Optionausübung $115,525
1 Mar 2022
Georgina Wraight
See Remarks
Optionausübung $48,407
27 Feb 2022
Georgina Wraight
See Remarks
Optionausübung $435,450
14 Jan 2022
Georgina Wraight
See Remarks
Optionausübung $99,143
27 Feb 2021
Georgina Wraight
See Remarks
Verkauf $400,000
10 Feb 2021
Georgina Wraight
See Remarks
Optionausübung $1,028,234
14 Jan 2021
Georgina Wraight
See Remarks
Optionausübung $86,000
15 Oct 2020
Georgina Wraight
See Remarks
Optionausübung $86,000
29 Sep 2020
Georgina Wraight
See Remarks
Optionausübung $129,000
25 Sep 2020
Georgina Wraight
See Remarks
Optionausübung $28,574
27 Feb 2020


Covetrus executives and stock owners

Covetrus executives and other stock owners filed with the SEC include: